Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.04/Share
Get Alerts AUPH Hot Sheet
Join SI Premium – FREE
Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.04), versus ($0.21) reported last year.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- KB Home (KBH) PT Lowered to $50 at RBC Capital
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share